Back
Myriad Genetics Vs. Perspective Therapeutics Industry Stock Comparison
Sell
19
MYGN
Myriad Genetics
Last Price:
$13.67
Seasonality Move:
3.46%
Sell
25
CATX
Perspective Therapeutics
Last Price:
$3.50
Seasonality Move:
43.39%
Sell
19
Myriad Genetics (MYGN)
is a Sell
Is Myriad Genetics a Buy, Sell or Hold?
-
The current Myriad Genetics [MYGN] share price is $13.67. The Score for MYGN is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
MYGN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
25
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
-
The current Perspective Therapeutics [CATX] share price is $3.51. The Score for CATX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MYGN Stock Price Chart
What is Myriad Genetics's stock price today?
-
The Myriad Genetics share price today is $13.67Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYGN is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
MYGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.85 | Sell |
Relative Strength Index (14 RSI): | 35.58 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.37 - 15.73) | Sell |
Bollinger Bands (100): | (15.79 - 27.13) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.79 | Sell |
Relative Strength Index (14 RSI): | 37.48 | Sell |
Chaikin Money Flow: | 704863 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.07 - 3.87) | Buy |
Bollinger Bands (100): | (5.54 - 14.76) | Sell |
MYGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.6 | Buy |
20-day SMA: | 14.08 | Sell |
50-day SMA: | 16.25 | Sell |
200-day SMA: | 22.37 | Sell |
8-day EMA: | 13.64 | Buy |
20-day EMA: | 14.21 | Sell |
50-day EMA: | 16.54 | Sell |
200-day EMA: | 20.87 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.24 | Buy |
20-day SMA: | 3.32 | Buy |
50-day SMA: | 6.48 | Sell |
200-day SMA: | 11.89 | Sell |
8-day EMA: | 3.27 | Buy |
20-day EMA: | 3.68 | Sell |
50-day EMA: | 5.95 | Sell |
200-day EMA: | 9.5 | Sell |
Myriad Genetics Earnings Growth & MYGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.31 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.35 per share.
Myriad Genetics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |